US Stock MarketDetailed Quotes

ALLK Allakos

Watchlist
  • 1.050
  • -0.020-1.87%
Close Dec 13 16:00 ET
  • 1.079
  • +0.029+2.79%
Post 16:29 ET
93.81MMarket Cap-0.52P/E (TTM)

About Allakos Company

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.

Company Profile

SymbolALLK
Company NameAllakos
Listing DateJul 19, 2018
Issue Price18.00
Founded2012
CEODr. Robert Alexander, PhD
MarketNASDAQ
Employees131
Fiscal Year Ends12-31
Address825 Industrial Road,Suite 500
CitySan Carlos
ProvinceCalifornia
CountryUnited States of America
Zip Code94070
Phone1-650-597-5002
Websitehttp://www.allakos.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert Alexander, PhD
  • Director and Chief Executive Officer
  • 6.30M
  • H. Baird Radford,III
  • Chief Financial Officer and Principal Accounting Officer
  • 2.74M
  • Dr. Chin Lee, M.D.,M.P.H.
  • Chief Medical Officer
  • --
  • Daniel S. Janney
  • Chairman of the Board
  • 434.62K
  • Dr. Adam Tomasi, PhD
  • President
  • 4.27M
  • Dr. Neil Graham, M.B.B.S.,M.D.,M.P.H.
  • Independent Director
  • 378.28K
  • Dr. Everett Rand Sutherland, M.D.
  • Independent Director
  • 732.48K
  • Steven P. James
  • Independent Director
  • 387.12K
  • Dr. Dolca Thomas, M.D.
  • Independent Director
  • 732.48K
  • Dr. Amy L. Ladd, M.D.
  • Independent Director
  • 372.12K
  • Robert E. Andreatta
  • Independent Director
  • 389.62K
  • Paul Walker
  • Independent Director
  • 387.12K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List